Back to first-pass browser

First-pass extracted concept

GABAergic LPBN neurons

Candidate: concept label1 source documents4 linked claims
Jump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Evidence Snippets

Optogenetic activation of GABAergic LPBN neurons alleviates neuropathic pain-like behavior, and repetitive pharmacogenetic activation of GABAergic LPBN neurons prevents development of CPN ligation-induced neuropathic pain-like hypersensitivity.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1causal perturbation effectsupports2020Source 1DOIPubMed

Optogenetic activation of GABAergic LPBN neurons alleviates neuropathic pain-like behavior without affecting basal nociception.

Claim 2causal perturbation effectsupports2020Source 1DOIPubMed

Optogenetic activation of glutamatergic LPBN neurons or inhibition of GABAergic LPBN neurons induces neuropathic pain-like behavior in naive mice.

Claim 3causal perturbation effectsupports2020Source 1DOIPubMed

Repetitive pharmacogenetic activation of glutamatergic LPBN neurons mimics development of CPN ligation-induced neuropathic pain-like hypersensitivity, whereas repetitive pharmacogenetic activation of GABAergic LPBN neurons prevents it.

Claim 4mechanistic modelsupports2020Source 1DOIPubMed

A balance between excitatory and inhibitory LPBN neuronal activity governs the development and maintenance of neuropathic pain.